1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Global Molecular Diagnostics Market Report: 2015 Edition

Global Molecular Diagnostics Market Report: 2015 Edition

  • June 2015
  • -
  • Koncept Analytics
  • -
  • 48 pages

Molecular diagnostics is a dynamic and transformative area of diagnostics, leading to insights in research and treatment in many disease states that are revolutionizing health care. Molecular diagnostics detects and measures the presence of genetic material or proteins associated with a specific health condition or disease, helping to uncover the underlying mechanisms of disease and enabling clinicians to tailor care at an individual level facilitating the practice of personalized medicine.

Molecular diagnostics today is routinely used in hospitals, reference labs, and blood banks. In the latter, molecular tests are used to screen donated blood products for infectious diseases like hepatitis and HIV. In hospitals, testing is often performed to identify pathogens in patients with infections. In fact, infectious diseases are one of the strongest growing areas within the molecular diagnostics field. There is also increasing demand for such technologies at the point of care.

The report “Global Molecular Diagnostics Market” provides an in-depth analysis of the molecular diagnostics market along with a detailed study of its various segments. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The four major players in the industry, Roche Holding AG, Qiagen NV, Abbott Laboratories and Novartis are being profiled.

The key factors driving the growth of the molecular diagnostics industry are rising incidence of chronic and infectious disease, rising awareness and acceptance of personalized medicine, expansion in emerging countries, ageing population and technological developments. Some of the noteworthy trend and developments of this industry are growth of next generation sequencing and growth in point of care diagnostics. However, the expansion of global molecular diagnostics industry is hindered by challenges in genetic diagnostics and regulatory issues.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Table Of Contents

Global Molecular Diagnostics Market Report: 2015 Edition
1. Diagnostics: An Overview

1.1 In Vitro Diagnostics
1.2 Molecular Diagnostics

2. Diagnostics Market

2.1 Global In Vitro Diagnostics (IVD) Market
-Market Value
-Market Segmentation

2.2 Global Molecular Diagnostics Market
-Market Value
-Market Segmentation

2.2.1 Human Papilloma Virus (HPV)
-Global Market Value
-Global Market Volume

2.2.2 CT/NG
-Global Market Value
-Global Market Volume

2.2.3 Global Genetic Testing Market
-Global Market Value

3. Market Dynamics

3.1 Industry Trends and Developments

3.1.1 Growth of Next Generation Sequencing (NGS)
3.1.2 Growth in Point-of-Care Diagnostics
3.1.3 Growth in Non-Invasive Prenatal Testing (NIPT)

3.2 Growth Drivers

3.2.1 Rising Incidence of Chronic and Infectious Diseases
3.2.2 Technological Developments
3.2.3 Rising Awareness and Acceptance of Personalized Medicine
3.2.4 Economic Growth
3.2.5 Expansion in Emerging Countries
3.2.6 Ageing Population Worldwide
3.2.7 Rising Healthcare Expenditure

3.3 Issues and Challenges

3.3.1 Challenges in Genetic Diagnostics
3.3.2 Regulatory Issues

4. Competitive Landscape
-Molecular Diagnostics Market Share
-CT/NG Market Share
-HPV Market Share

5. Company Profiles

5.1 Roche Holding AG

5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies

5.2 Qiagen NV

5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies

5.3 Abbott Laboratories

5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies

5.4 Novartis

5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies

6. Market Outlook

6.1 Market Forecast

6.2 Forecast Methodology

6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Charts

IVD Market - Segments by Technology
Molecular Diagnostics - Traditional Process
Main Purposes of Molecular Diagnostics
IVD Market by Product Segments (2014)
Global IVD Market (2011-2016E)
Global IVD Market Share by Segment (2014)
Global Molecular Diagnostics Market (2009-2014)
Molecular Diagnostics Market Share by Segment (2014)
Molecular Diagnostics Market Share by Test Type (2014)
Global HPV Market by Value (2010-2014)
Global HPV Market by Volume (2010-2014)
Global CT/NG Market by Value (2011-2015E)
Global CT/NG Market by Volume (2011-2015E)
Global Genetic Testing Market (2007-2014)
Global GDP (2006-2013)
Global Ageing Population (2006-2014)
Global Healthcare Spending (2005-2014)
Global Molecular Diagnostic Market Share by Company (2014)
Global IVD Market Share by Company (2014E)
Global CT/NG Market Share by Company (2014)
Global HPV Market Share by Company (2014)
Roche's Revenues by Business Segments (2014)
Share of Diagnostics' Revenues by Sub-Segments, Roche (2014)
Roche's Net Sales and Net Income (2010-2014)
Qiagen's Revenue Share by Customer Classes Served (2014)
Qiagen's Revenue Share by Region (2014)
Qiagen's Net Sales and Net Income (2010-2014)
Abbott Laboratories Revenue Share by Segments (2014)
Abbott Laboratories Revenue and Net Income (2010-2014)
Novartis' Revenue Share by Business Segments (2014)
Novartis' Net Sales and Net Income (2010-2014)
Global Molecular Diagnostics Market Forecast (2014-2018E)

List of Tables

Financial Comparison of Key Players (2014)
Dependent and Independent Variables (2009-2014)
Correlation Matrix
Model Summary - Coefficient of Determination
Regression Coefficients Output

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.